Researchers have identified a novel therapeutic approach for colorectal cancer by exploiting a specific genetic vulnerability found in a majority of patients. The study focuses on the adenomatous ...

LGM Pharma is expanding capabilities in Texas and Colorado, and went in depth about these investments at DCAT Week 2026.

For most patients diagnosed with kidney cancer, the standard playbook is clear. Immunotherapy and targeted therapies directed ...

Venkata Sarath Maddali designs modular, scalable healthcare architectures that integrate pharmaceutical operations, insurance ...